Vetter contract development and manufacturing organisation (CDMO) is building a state-of-the-art, high-performance filling line for syringes at its Ravensburg Vetter South location. The line can handle batches of up to one million units per day and is particularly well suited for the aseptic filling of high-volume products, like vaccines.
The company is also expanding its services for the early clinical phases of new drugs. At its Vetter Development Service locations in Chicago, Illinois (US), and Ravensburg (Germany), the company offers a wide range of services including formulation support and customised packaging development. With another new filling line at the Ravensburg facility and further investments planned in Chicago, Vetter continues to increase its capabilities in clinical manufacturing.
Vetter is reinforcing its position as a strategic partner for the development and commercial manufacturing of parenteral drugs. With the expansion in capacity and service portfolio, Vetter is providing efficient answers to the growing demand for prefilled syringes throughout a product lifecycle. Vetter Development Service supports customers in efficiently transferring new drugs from early stage phase to commercial manufacturing including regulatory support. The company’s comprehensive know-how in process- and packaging development in aseptic filling is used to support a high-professional clinical offering.
“Vetter is continuously and strategically investing in its partnerships with international customers,” says Peter Soelkner, Managing Director, Vetter. “In the area of prefilled syringes we provide our partners a full range of service, from small batches manufacturing and support in early clinical stages to high-volume manufacturing for large scale commercial production.”
EP News Bureau — Mumbai
- Advertisement -
